Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment
P-glycoprotein (P-gp) efflux is the major cause of multidrug resistance (MDR) in tumors when using anticancer drugs, moreover, poor bioavailability of few drugs is also due to P-gp efflux in the gut. Rapamycin (RPM) is in the clinical trials for breast cancer treatment, but its P-gp substrate proper...
Saved in:
| Published in: | Drug delivery Vol. 23; no. 7; pp. 2608 - 2616 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Taylor & Francis
01.09.2016
|
| Subjects: | |
| ISSN: | 1071-7544, 1521-0464 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!